Paper

Glycine transporter I inhibitor, N-Methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia

Published Mar 1, 2004 · G. Tsai, H. Lane, Pinchen Yang

Biological Psychiatry

348

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCTRigorous JournalHighly Cited

Study Snapshot

Sarcosine treatment, when added to antipsychotics, significantly improves symptoms in schizophrenic patients, supporting the hypothesis of N-methyl-D-aspartate receptor hypofunction in schizophrenia.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Glycine transporter I inhibitor, N-Methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia

References

Citations